Contract development TDS ODF

Benefit from our experience and develop your new formula with us. We will advise you and then together we will create an initial development plan and support you until needs-oriented production has been properly established.

Our standardised development approach enables us – after a short evaluation phase – to create formulations for optimised use of the drugs in transdermal applications.

In addition to “well-known” drugs, we also work with “new” substances (NCE) that are still in the relatively early clinical development stages. We also follow systematic development approaches for these substances. Accordingly, we are able to establish relatively quickly the extent to which new substances are suitable for transdermal application.

We are also able to work with highly active substances for which special safety standards apply.

Vektor Pharma TF GmbH – Therapeutische Filme | Hauptstraße 13 | 88524 Uttenweiler | Tel: +49-7374-383000 |

Copyright © 2024 Vektor Pharma